Other Science
476 articles
Let’s Win! Pancreatic Cancer Survivors Series—Year Three
Let’s Win kicks off Year Three of its Survivors Series of videos. The 2020 videos will feature patients with genetic mutations and more researchers.
Pancreatic Neuroendocrine Tumor Caught By Chance
When Jason McMurtrie found out he had a pancreatic neuroendocrine tumor he chose laparoscopic surgery; now he’s back traveling with his wife.
Let’s Learn Webinar on Clinical Trials on October 28th
Join Let’s Win for a webinar on the Importance of Clinical Trials, to learn more about participating in a trial as part of treatment.
Should Cancer Patients Get the COVID-19 Vaccine? Yes!
Should pancreatic cancer patients get the COVID-19 vaccine? According to the experts, yes, and as soon as they can.
Let’s Win Announces Let’s Learn Webinar Series
Are you a health care professional who wants to know more about the risks, symptoms, and treatments for pancreatic cancer? Join our webinars!
No Time to Wait: UK Pancreatic Cancer Patients Struggle with Treatment and Diagnostic Delays
Peter De Rosa of Pancreatic Cancer UK provides an update on how the COVID-19 pandemic has impacted pancreatic cancer patients in the UK.
COVID-19—An Update
What is the status of international and US travel? Which states have mask mandates? Are vaccines progressing? Read our COVID-19 update for more information.
Researching More Second-Line Options for Pancreatic Cancer
Dr. Allyson Ocean explains the concept behind a novel second-line treatment being tested for metastatic pancreatic cancer.
Disappointing Results of a Phase II Trial Using Angiogenesis Inhibitor
Dr. Tanios Bekaii-Saab reports on the disappointing results of a trial combining an angiogenesis inhibitor and mFOLFIRINOX.
New Data Support Preoperative Chemoradiation Regimen for Borderline Resectable Pancreatic Cancer
Should patients get chemotherapy or chemoradiation before surgery? Dr. Matthew Katz provides an update on the Alliance study.
Molecular Profiling: Getting to Know Your Tumor
Dr. Johanna Bendell explains the value of molecular profiling, which can indicate the best type of chemotherapy for your tumor.
New Study Aims to Reduce Recurrence Risk for Select Patients
Dr. Kim A. Reiss is leading a study of the PARP inhibitor olaparib to delay or prevent a recurrence of surgically removed pancreatic cancer.
High-Dose Vitamin C Targeting KRAS and BRAF in Pancreatic Cancer
Learn how Dr. Manish Shah is leading clinical trials using high-dose Vitamin C to target KRAS and BRAF mutations in pancreatic cancer.
Liquid Biopsies: What You Should Know
Three different liquid biopsy blood tests are under development or now available for pancreatic and other cancers.
New Guidelines on the Use of Radiation for Pancreatic Cancer Treatment
New clinical guidelines from the American Society for Radiation Oncology will help clarify the best uses of radiation treatment for pancreatic cancer.